Page last updated: 2024-08-23

paroxetine and Premenstrual Tension

paroxetine has been researched along with Premenstrual Tension in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (15.00)	18.2507
2000's	15 (75.00)	29.6817
2010's	2 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anonychuk, AM; Carter, D; Huang, JO; LeMelledo, JM; Ravindran, AV; Simpson, SD; Steiner, M	1
Andersch, B; Bengtsson, F; Eriksson, E; Erlandsson, H; Landén, M	1
Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M	1
Dobzhenko, MN; Shchepotin, IB; Zotov, AS	1
Hsiao, MC; Liu, CY	1
Baghei, F; Ekman, A; Eriksson, E; Eriksson, O; Landén, M; Melke, J; Rosmond, R; Sundblad, C; Westberg, L	1
Yonkers, KA	1
Bang, LM; Keating, GM	1
Ekman, A; Eriksson, E; Landén, M; Modigh, K; Nissbrandt, H; Olsson, M; Sörvik, K; Tygesen, H; Wennerblom, B; Ysander, C	1
Bergeron, R; Gee, MD; Hirschberg, AL; Holland, F; Steiner, M; Van Erp, E	1
Holthausen, GA; Howell, HB; Poschman, K; Yonkers, KA	1
Allgulander, C; Eriksson, E; Landén, M; Nissbrandt, H; Sörvik, K; Ysander, C	1
Inoue, Y; Iwata, N; Kojima, H; Nakamura, J; Okamoto, K; Okamoto, T; Terao, T; Yoshimura, R	1
Hsiao, MC; Liu, CY; Wu, KY	1
Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R	1
Andersch, B; Eriksson, E; Hedberg, MA; Sundblad, C	1
Gullion, C; Novak, K; Rush, AJ; Williams, A; Yonkers, KA	1
Andersch, B; Eriksson, E; Sundblad, C; Wikander, I	1
Allard, P; Bäckström, T; Bixo, M; Mjörndal, T; Nyberg, S; Spigset, O; Sundström-Poromaa, I	1
Allard, P; Bäckström, T; Mjörndal, T; Spigset, O; Sundström-Poromaa, I; Wihlbäck, AC	1

Reviews

4 review(s) available for paroxetine and Premenstrual Tension

Article	Year
[Selective serotonin reuptake inhibitors and mammary pathologies]. Voprosy onkologii, 2010, Volume: 56, Issue:4 Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Mood Disorders; Paroxetine; Premenstrual Syndrome	2003
Paroxetine controlled release. CNS drugs, 2004, Volume: 18, Issue:6 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Delayed-Action Preparations; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Odds Ratio; Paroxetine; Practice Guidelines as Topic; Premenstrual Syndrome; Psychiatric Status Rating Scales	2004
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2008

Trials

13 trial(s) available for paroxetine and Premenstrual Tension

Article	Year
Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:6 Topics: Adolescent; Adult; Canada; Double-Blind Method; Drug Administration Schedule; Female; Humans; Luteal Phase; Middle Aged; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors	2008
Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3 Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Irritable Mood; Luteal Phase; Menstrual Cycle; Nausea; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Self-Assessment; Time Factors	2009
Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology, 2003, Volume: 28, Issue:3 Topics: Adolescent; Adult; Blood Platelets; Carrier Proteins; Female; Gene Frequency; Genotype; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Polymorphism, Genetic; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins	2003
Heart rate variability in premenstrual dysphoric disorder. Psychoneuroendocrinology, 2004, Volume: 29, Issue:6 Topics: Adult; Autonomic Nervous System; Double-Blind Method; Electrocardiography, Ambulatory; Female; Follicular Phase; Heart; Heart Rate; Humans; Luteal Phase; Matched-Pair Analysis; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors	2004
Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder. American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:2 Topics: Adolescent; Adult; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Luteal Phase; Middle Aged; Pain Measurement; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors	2005
Symptom-onset treatment for women with premenstrual dysphoric disorder. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2 Topics: Adult; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Menstrual Cycle; Paroxetine; Patient Compliance; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2006
Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:1 Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Female; Humans; Pain Measurement; Paroxetine; Placebos; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Paroxetine; Premenstrual Syndrome; Taiwan; Treatment Outcome	2008
The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1995, Volume: 12, Issue:2 Topics: Double-Blind Method; Female; Humans; Maprotiline; Paroxetine; Placebos; Premenstrual Syndrome; Treatment Outcome	1995
Paroxetine as a treatment for premenstrual dysphoric disorder. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Premenstrual Syndrome; Psychiatric Status Rating Scales	1996
A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1997, Volume: 7, Issue:3 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety; Appetite; Body Water; Female; Humans; Paroxetine; Premenstrual Syndrome; Psychiatric Status Rating Scales	1997
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment. Psychoneuroendocrinology, 2001, Volume: 26, Issue:6 Topics: Adult; Blood Platelets; Buserelin; Cross-Over Studies; Double-Blind Method; Female; Follicular Phase; Humans; Luteal Phase; Lysergic Acid Diethylamide; Paroxetine; Placebos; Premenstrual Syndrome; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tritium	2001
Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding. Obstetrics and gynecology, 2001, Volume: 98, Issue:3 Topics: Blood Platelets; Carrier Proteins; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lysergic Acid Diethylamide; Medroxyprogesterone Acetate; Middle Aged; Paroxetine; Premenstrual Syndrome; Progesterone Congeners; Radioligand Assay; Receptors, Serotonin	2001

Other Studies

3 other study(ies) available for paroxetine and Premenstrual Tension

Article	Year
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder. Applied health economics and health policy, 2010, Volume: 8, Issue:2 Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Antidepressant-related hypomania in a patient with premenstrual dysphoric disorder. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Female; Humans; Paroxetine; Premenstrual Syndrome	2002
Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests. Psychopharmacology, 2007, Volume: 190, Issue:2 Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Affective Symptoms; Female; Follicular Phase; Humans; Hydrocortisone; Luteal Phase; Paroxetine; Premenstrual Syndrome; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin	2007